Shree Hari Chemicals Export Ltd Hits All-Time High of Rs 338 as Momentum Builds Across Timeframes

Price Action and Recent Performance

On the day of the record close, Shree Hari Chemicals Export Ltd gained 4.05%, contrasting with the Sensex's 1.05% decline. This performance capped a spectacular one-month surge of 111.45% and a three-month rally of 194.04%, dwarfing the Sensex's negative returns over the same periods. The stock’s year-to-date gain of 158.02% further emphasises its outperformance in a challenging market environment. However, the day also saw a 4.99% intraday low, indicating some profit-taking pressure after five consecutive days of gains. Is this a pause before further upside or a signal of near-term consolidation?

Technical Indicators Signal Strong Momentum

The technical landscape for Shree Hari Chemicals Export Ltd is predominantly bullish. The stock trades above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, a classic sign of sustained upward momentum. Weekly and monthly MACD and Bollinger Bands indicators are bullish, reinforcing the positive trend. However, the Relative Strength Index (RSI) remains bearish on both weekly and monthly charts, suggesting the stock may be overextended in the short term. This divergence between momentum and RSI hints at a potential correction or sideways movement in the near future. The 20-day moving average at Rs 253.08 and the 52-week high of Rs 324.85 represent key technical levels to watch. How sustainable is this technical momentum given the mixed signals from RSI?

Key Data at a Glance

Financial Performance and Growth Trajectory

The recent quarterly results highlight a robust financial trend for Shree Hari Chemicals Export Ltd. Net sales for the latest six months reached ₹96.13 crores, growing 61.97% year-on-year. Operating profit margin hit a record 15.44%, with PBDIT at ₹8.48 crores and PAT at ₹5.92 crores, both the highest recorded. The company’s net profit growth of 469.23% in the latest quarter underscores a strong earnings momentum. However, the return on capital employed (ROCE) remains modest at 6.1%, which is relatively low given the valuation multiples. This gap between profit growth and capital efficiency raises questions about the sustainability of such rapid expansion. Can the company maintain this pace of profit growth while improving capital returns?

Valuation: Premium Pricing Amidst Growth

At a trailing twelve-month P/E of 18x, Shree Hari Chemicals Export Ltd trades at a premium relative to many peers in the commodity chemicals sector. The price-to-book ratio of 4.63x and EV/EBITDA of 14.07x further indicate stretched valuations. The PEG ratio of 0.11x suggests that earnings growth is currently outpacing the price increase, but the relatively low ROCE and moderate leverage temper enthusiasm. The enterprise value to capital employed ratio of 3.3x is notably high, signalling that investors are paying a significant premium for the company’s capital base. At these valuations, should you be booking profits on Shree Hari Chemicals Export Ltd or can the company grow into this premium?

Quality Metrics and Promoter Confidence

The company’s quality indicators present a mixed picture. While the five-year sales CAGR of 24.23% and EBIT growth of 70.94% reflect strong expansion, the average ROCE of 11.17% and ROE of 12.62% are modest. Capital structure metrics show moderate leverage with a net debt-to-equity ratio of 0.58 and debt-to-EBITDA of 3.93. Importantly, promoters have increased their stake by 5.01% over the previous quarter, now holding 64.26%, signalling confidence in the company’s prospects. The absence of pledged shares further supports a stable ownership structure. How does promoter confidence align with the company’s financial quality and risk profile?

Balancing the Bull and Bear Cases

The stock’s extraordinary returns over the past year—214.42% compared to the Sensex’s decline of 9.39%—reflect a powerful growth story. The company’s operating profit growth at an annual rate of 70.94% and net profit surge of 469.23% in the latest quarter are compelling. Yet, the relatively low ROCE and stretched valuation multiples introduce caution. The technical indicators mostly support continued momentum, but the bearish RSI warns of potential short-term fatigue. Investors face a classic tension between strong earnings growth and premium pricing. Should you buy, sell, or hold? With momentum and valuations pulling in opposite directions, no single data point tells the full story — see the complete multi-factor analysis of Shree Hari Chemicals Export Ltd to find out.

Conclusion

Shree Hari Chemicals Export Ltd has reached a significant milestone by hitting an all-time high of Rs 338, backed by robust financial growth and strong technical momentum. However, the stretched valuations and moderate capital efficiency metrics suggest that investors should weigh the impressive earnings growth against the premium being paid. The recent intraday volatility and bearish RSI add nuance to the outlook, indicating that while the momentum is supportive, caution may be warranted in the near term.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →